Figure 2.

The supernatant of GBM cells treated with VB inhibits microtubule formation

(A) The effect of supernatant of U87 and U251 cells on microtubule formation after 48 h of treatment with different concentrations of VB (×400). (B) Tube length and the number of tubes are quantified for (A). (C) The effect of different concentrations of VB on microtubule formation of GBM cells (×400). (D) Tube length and the number of tubes are quantified for (C). Data were shown as mean ± standard deviation of three technical replicates. One-way ANOVA was used for data comparison in panel B and D, with Tukey’s post-test test. ∗p < 0.05, compared with the previous drug concentration.